Review of multimodal deep learning model for esophageal squamous cell carcinoma diagnosis
New AI tool spots esophageal cancer early with expert accuracy
This review synthesizes a model development and validation study for esophageal squamous cell carcinoma.
A new AI system matches expert doctors in spotting early esophageal cancer. This could change how patients get diagnosed.
Deep learning segmentation with CT elasticity features predicts right recurrent laryngeal nerve metastasis in esophageal cancer
AI Can Spot Hidden Cancer Spread in the Neck Before Surgery
This retrospective cohort study of 415 patients with esophageal squamous cell carcinoma evaluated a deep learning-based segmentation model w…
This research could help surgeons avoid damaging a vital nerve during esophageal cancer surgery, making operations safer and more precise.
Neoadjuvant Chemoimmunotherapy Alters Tumor Microenvironment in Esophageal Cancer
Combination therapy may help overcome resistance in esophageal cancer
This Phase 3 RCT in 55 patients with locally advanced esophageal squamous cell carcinoma compared neoadjuvant chemotherapy alone versus comb…
A small trial suggests combination therapy might help overcome resistance in esophageal cancer by targeting specific immune cells.
Timing of surgery after neoadjuvant chemoimmunotherapy impacts survival in operable esophageal squamous cell carcinoma
Shrink Faster, Live Longer: Timing Saves Lives in Esophageal Cancer
This multicenter retrospective cohort study evaluated 163 patients with operable esophageal squamous cell carcinoma receiving neoadjuvant…
Faster tumor shrinkage and surgery within six weeks of treatment predict longer survival for esophageal cancer patients receiving new therap…
PD-1 inhibitors + chemo improve OS, PFS, ORR in first-line advanced ESCC; benefit limited in PD-L1 CPS <1
Who benefits most from new esophageal cancer treatment? Most patients do, except one group
A meta-analysis of 8 RCTs (n=4702) found first-line PD-1 inhibitors plus chemotherapy significantly improved OS (HR=0.68, 95% CI: 0.63-0.74;…
For most advanced esophageal cancer patients, adding immunotherapy to chemotherapy extends life and shrinks tumors, but those with low PD-L1…
Research across Head and Neck Cancer
Related studies from across the Head and Neck Cancer family.
Submental Artery Island Flap Shows 16% Pooled Locoregional Recurrence in Oral Cavity Reconstruction
Submental artery island flap is a safe option for oral cancer
This meta-analysis pooled data on the submental artery island flap (SAIF) for oral cavity defects after oral squamous cell carcinoma resecti…
A specific surgical technique called the submental artery island flap shows a low recurrence rate for patients with oral cavity defects.
Impact of Perineural Invasion on Survival Outcomes in Oral Squamous Cell Carcinoma
Perineural invasion linked to poorer outcomes in oral squamous cell carcinoma
A meta-analysis of 23,580 patients confirms that perineural invasion is a potent independent predictor of poor survival and high recurrence …
A large review of over 23,000 patients shows that cancer cells spreading along nerves are linked to higher recurrence and lower survival rat…
Cetuximab-based regimens achieve 47% objective response rate in HNSCC after immune checkpoint inhibitor failure
Cetuximab shows activity for head and neck cancer patients
This meta-analysis evaluates cetuximab-based regimens for patients with recurrent or metastatic head and neck squamous cell carcinoma follow…
New data shows cetuximab-based treatments provide meaningful results for head and neck cancer patients after other treatments fail.
AI-based MRI shows 0.82 AUC for detecting cervical lymph node metastases in oral squamous cell carcinoma
AI tools help detect lymph node spread in oral cancer
This meta-analysis of 548 patients evaluates AI-based MRI for detecting cervical lymph node metastases in oral squamous cell carcinoma. The …
Artificial intelligence may help doctors better identify if oral cancer has spread to lymph nodes before surgery.
Immune cell-based therapy shows no significant benefits for tumor response or survival in HNSCC trials
Immune cell therapy shows limited promise for head and neck cancer
This meta-analysis of 30 trials involving 953 patients evaluated immune cell-based therapy (ICT) for head and neck squamous cell carcinoma. …
New data on immune cell-based therapies for head and neck cancer shows mixed results and a need for more rigorous testing.
Perioperative and postoperative immunotherapy timing determines clinical outcomes in locally advanced head and neck squamous cell carcinoma
Timing of immunotherapy affects outcomes for head and neck cancer
This narrative review examines the impact of immunotherapy sequencing on patients with locally advanced head and neck squamous cell carcinom…
The timing of immunotherapy treatment significantly changes how well it controls local and distant spread in head and neck cancer.
HPV16 constitutes 92.5% of single infections in oropharyngeal squamous cell carcinoma cases
HPV16 Remains the Most Common Type in Throat Cancer
This meta-analysis of 183 studies involving 17,443 patients identifies HPV16 as the predominant genotype in oropharyngeal squamous cell carc…
A large global study of over 17,000 cases shows that HPV16 is the primary driver of most HPV-related throat cancers.
Higher preoperative neutrophil-to-lymphocyte ratio predicts poorer survival in oral squamous cell carcinoma patients
High white blood cell ratios predict survival in oral cancer
This meta-analysis of 30 studies indicates that a higher preoperative neutrophil-to-lymphocyte ratio (NLR) is significantly associated with …
A high ratio of neutrophils to lymphocytes before surgery can help doctors predict survival outcomes for patients with oral squamous cell ca…
ALC decline greater than 0.74x10^9/L independently predicts poorer OS and PFS in LA-HNSCC
Lymphocyte Drop During Radiation Tied to Worse Head and Neck Cancer Outcomes
This post-hoc analysis of a phase III trial involved 222 patients with locally advanced head and neck squamous cell carcinoma. The study fou…
A large drop in lymphocytes during radiation for head and neck cancer is linked to poorer survival. This finding may help personalize treatm…
Deep Learning algorithms demonstrate potential for diagnosing oral potentially malignant disorders and squamous cell carcinoma
Artificial Intelligence Shows Potential for Detecting Oral Cancer
This meta-analysis evaluated the diagnostic accuracy of deep learning models using white light digital photographs to identify oral malignan…
New research shows that deep learning tools can help identify oral cancer and precancerous conditions using simple digital photos.
PD-1/PD-L1 inhibitors provide superior overall survival compared to chemotherapy or cetuximab in platinum-refractory HNSCC
Newer drugs show better survival for advanced head and neck cancer
This meta-analysis of 5 RCTs involving 1,700 patients found that PD-1/PD-L1 inhibitors resulted in superior overall survival (HR: 0.80) comp…
A review of clinical trials shows that certain immunotherapy drugs offer better survival rates and fewer severe side effects than traditiona…
Ninjin’yoeito attenuates postoperative Prognostic Nutritional Index decline in patients with oral squamous cell carcinoma
Ninjin’yoeito may help patients with oral squamous cell carcinoma
This single-arm clinical trial evaluated the impact of Ninjin’yoeito on nutritional status in patients with oral squamous cell carcinoma und…
A small study suggests that Ninjin’yoeito could help maintain nutritional health in patients undergoing surgery for oral cancer.
Questions about Esophageal Squamous Cell Carcinoma
How does neoadjuvant chemoimmunotherapy change the tumor environment in esophageal squamous cell carcinoma?
Neoadjuvant chemoimmunotherapy remodels the tumor microenvironment in ESCC by increasing cytotoxic CD8+ T cells, dendritic cell remodeling, and reducing tumor volume, which correlates with better pathological response and survival.
Full answer →Does gastroesophageal reflux disease increase the risk of laryngeal cancer or esophageal squamous cell carcinoma?
GERD increases the risk of laryngeal cancer but not esophageal squamous cell carcinoma, according to a large meta-analysis.
Full answer →Is S-1 medication better than radiation alone for elderly patients with esophageal squamous cell carcinoma?
Yes, S-1 plus radiation improves survival over radiation alone for elderly patients with inoperable esophageal squamous cell carcinoma, based on a phase III trial.
Full answer →Can a deep learning model help diagnose esophageal squamous cell carcinoma more accurately?
Yes, deep learning models can help diagnose esophageal squamous cell carcinoma more accurately, with studies showing high AUC values for tumor detection and lymph node metastasis prediction.
Full answer →Does adding radiation to chemotherapy help esophageal squamous cell carcinoma patients live longer?
Adding radiation to chemotherapy before surgery does not clearly improve overall survival for esophageal squamous cell carcinoma patients compared to chemotherapy alone, but it increases the chance of a complete tumor response.
Full answer →